Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer

Development and Validation of an 8-Gene Signature to Improve Survival Prediction of Colorectal Cancer

BackgroundMost prognostic signatures for colorectal cancer (CRC) are developed to predict overall survival (OS). Gene signatures predicting recurrence-free survival (RFS) are rarely reported, and postoperative recurrence results in a poor outcome. Thus, we aim to construct a robust, individualized g...

Full description

Bibliographic Details
Main Authors: Leqi Zhou, Yue Yu, Rongbo Wen, Kuo Zheng, Siyuan Jiang, Xiaoming Zhu, Jinke Sui, Haifeng Gong, Zheng Lou, Liqiang Hao, Guanyu Yu, Wei Zhang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Oncology
Subjects:
colorectal cancer
risk score
overall survival
recurrence-free survival
prognostic signature
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.863094/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.863094/full

Similar Items